Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert D Fraser

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Therapeutic Drug Monitoring|March 19, 2002
Clinical toxicologic implications of ethylene glycol and glycolic acid poisoningAlbert D Fraser
Therapeutic Drug Monitoring|July 2, 2004
Doping control from a global and national perspectiveAlbert D Fraser
Therapeutic Drug Monitoring|November 26, 2003
Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicatorsAlbert D Fraser, Jiri Zamecnik
Therapeutic Drug Monitoring|January 24, 2002
Substance abuse monitoring by the Correctional Service of CanadaAlbert D Fraser, Jiri Zamecnik
Forensic Science International|July 9, 2004
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IVAlbert D Fraser, David Worth
Forensic Science International|November 12, 2003
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio studyAlbert D Fraser, David Worth
Therapeutic Drug Monitoring|November 27, 2002
Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio studyAlbert D Fraser, David Worth
Forensic Science International|May 14, 2003
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2Albert D Fraser, David Worth
Clinical Biochemistry|December 21, 2002
Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analysesAlbert D Fraser, Lawrence Coffin, David Worth
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantationBryce A Kiberd, Joseph Lawen, Albert D Fraser, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|March 19, 2002
Clinical toxicologic implications of ethylene glycol and glycolic acid poisoningAlbert D Fraser
Therapeutic Drug Monitoring|July 2, 2004
Doping control from a global and national perspectiveAlbert D Fraser
Therapeutic Drug Monitoring|November 26, 2003
Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicatorsAlbert D Fraser, Jiri Zamecnik
Therapeutic Drug Monitoring|January 24, 2002
Substance abuse monitoring by the Correctional Service of CanadaAlbert D Fraser, Jiri Zamecnik
Forensic Science International|July 9, 2004
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IVAlbert D Fraser, David Worth
Forensic Science International|November 12, 2003
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio studyAlbert D Fraser, David Worth
Therapeutic Drug Monitoring|November 27, 2002
Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio studyAlbert D Fraser, David Worth
Forensic Science International|May 14, 2003
Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2Albert D Fraser, David Worth
Clinical Biochemistry|December 21, 2002
Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analysesAlbert D Fraser, Lawrence Coffin, David Worth
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantationBryce A Kiberd, Joseph Lawen, Albert D Fraser, et al.
Pageof 2